<p>The present invention provides NOTCH1 gene mutation as a biomarker that is predictive for the response and outcome after treatment with an anti-CD20 antibody in cancer patients.</p>
申请公布号
WO2014068133(A1)
申请公布日期
2014.05.08
申请号
WO2013EP73015
申请日期
2013.11.05
申请人
F. HOFFMANN-LA ROCHE AG;HOFFMANN-LA ROCHE INC.;UNIVERSITAETSKLINIKUM ULM;UNIVERSITAET ZU KOELN
